TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an update.
Imricor Medical Systems, Inc. announced a change in the director’s interest as Mr. Mark Tibbles acquired 41,280 Class A common stocks under the company’s Equity Incentive Plan. This acquisition, approved at the AGM on May 14, 2025, increases Mr. Tibbles’ total holdings to 6,272,193 shares, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on developing innovative products for cardiac ablation procedures. The company is known for its MRI-compatible devices, which are designed to improve the safety and efficacy of cardiac ablations.
Average Trading Volume: 417,906
See more data about IMR stock on TipRanks’ Stock Analysis page.